- Home
- AGL vs BCSF Comparison
AGL vs BCSF Comparison
Compare AGL & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGL
- BCSF
- Stock Information
- Founded
- AGL 2016
- BCSF 2015
- Country
- AGL United States
- BCSF United States
- Employees
- AGL N/A
- BCSF N/A
- Industry
- AGL Managed Health Care
- BCSF Finance/Investors Services
- Sector
- AGL Health Care
- BCSF Finance
- Exchange
- AGL Nasdaq
- BCSF Nasdaq
- Market Cap
- AGL 1.4B
- BCSF 1.2B
- IPO Year
- AGL 2021
- BCSF 2018
- Fundamental
- Price
- AGL $3.53
- BCSF $18.63
- Analyst Decision
- AGL Hold
- BCSF Hold
- Analyst Count
- AGL 18
- BCSF 4
- Target Price
- AGL $4.03
- BCSF $17.00
- AVG Volume (30 Days)
- AGL 5.1M
- BCSF 200.3K
- Earning Date
- AGL 02-25-2025
- BCSF 02-27-2025
- Dividend Yield
- AGL N/A
- BCSF 9.66%
- EPS Growth
- AGL N/A
- BCSF N/A
- EPS
- AGL N/A
- BCSF 1.99
- Revenue
- AGL $5,594,117,000.00
- BCSF $294,257,000.00
- Revenue This Year
- AGL $41.67
- BCSF N/A
- Revenue Next Year
- AGL $8.85
- BCSF N/A
- P/E Ratio
- AGL N/A
- BCSF $9.37
- Revenue Growth
- AGL 54.10
- BCSF 3.17
- 52 Week Low
- AGL $1.50
- BCSF $15.27
- 52 Week High
- AGL $7.73
- BCSF $18.77
- Technical
- Relative Strength Index (RSI)
- AGL 59.38
- BCSF 74.13
- Support Level
- AGL $3.32
- BCSF $17.71
- Resistance Level
- AGL $3.73
- BCSF $18.23
- Average True Range (ATR)
- AGL 0.24
- BCSF 0.25
- MACD
- AGL -0.03
- BCSF 0.04
- Stochastic Oscillator
- AGL 54.40
- BCSF 86.32
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes, First Lien Senior Secured Loan, Preferred Equity, Equity Interest, and Second Lien Senior Secured Loan among others.